Cargando…

Epidermolysis Bullosa Acquisita—Current and Emerging Treatments

Epidermolysis bullosa acquisita (EBA) is a rare chronic autoimmune subepidermal blistering disease of the skin and mucous membranes, usually beginning in adulthood. EBA is induced by autoantibodies to type VII collagen, a major component of anchoring fibrils in the dermal–epidermal junction (DEJ). T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tešanović Perković, Deša, Bukvić Mokos, Zrinka, Marinović, Branka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917799/ https://www.ncbi.nlm.nih.gov/pubmed/36769788 http://dx.doi.org/10.3390/jcm12031139

Ejemplares similares

Epidermolysis bullosa acquisita()
por: Miyamoto, Denise, et al.
Publicado: (2022)

Epidermolysis bullosa acquisita: current diagnosis and therapy
por: Mehren, Christine R., et al.
Publicado: (2011)

Epidermolysis Bullosa Acquisita: The 2019 Update
por: Koga, Hiroshi, et al.
Publicado: (2019)

Clinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita
por: Ludwig, Ralf J.
Publicado: (2013)

Epidermolysis Bullosa Acquisita: A Case Report
por: Kumetz, Erik A., et al.
Publicado: (2020)

New and Emerging Targeted Therapies for Hidradenitis Suppurativa
por: Markota Čagalj, Adela, et al.
Publicado: (2022)

Epidermolysis bullosa acquisita: an uncommon cause of esophageal stricture
por: Figueredo, Carlos, et al.
Publicado: (2021)

Epidermolysis Bullosa Acquisita: A Report of Four Cases
por: De, Abhishek, et al.
Publicado: (2022)

Acute renal failure in a patient with epidermolysis bullosa acquisita
por: Zhao, Guowei, et al.
Publicado: (2017)

Epidermolysis bullosa acquisita treated with ustekinumab: A case report
por: Prosty, Connor, et al.
Publicado: (2022)

Pemphigus—The Crux of Clinics, Research, and Treatment during the COVID-19 Pandemic
por: Marinović, Branka, et al.
Publicado: (2021)

EPIDERMOLYSIS BULLOSA ACQUISITA WITH MODERATELY SEVERE DYSPHAGIA DUE TO ESOPHAGEAL STRICTURES
por: Tu, Jenny, et al.
Publicado: (2011)

An atypical case of pediatric epidermolysis bullosa acquisita: Review of diagnosis and pitfalls
por: Patel, Ashaki, et al.
Publicado: (2021)

The development of mucous membrane epidermolysis bullosa acquisita in a pediatric patient
por: Rentfro, Kathryn, et al.
Publicado: (2021)

Cytoskeletal Regulation of Inflammation and Its Impact on Skin Blistering Disease Epidermolysis Bullosa Acquisita
por: Kopecki, Zlatko, et al.
Publicado: (2016)

Omega-3 Versus Omega-6 Polyunsaturated Fatty Acids in the Prevention and Treatment of Inflammatory Skin Diseases
por: Balić, Anamaria, et al.
Publicado: (2020)

Risk factors for non-melanoma skin cancer development in renal transplant recipients: a 40-year retrospective study in Croatia
por: Bašić-Jukić, Nikolina, et al.
Publicado: (2022)

Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients
por: Iwata, Hiroaki, et al.
Publicado: (2018)

Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice
por: Schönig, Sarah, et al.
Publicado: (2013)

T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita
por: Bieber, Katja, et al.
Publicado: (2016)

Case Report: Diagnostic and Therapeutic Challenges in Severe Mechanobullous Epidermolysis Bullosa Acquisita
por: Schauer, Franziska, et al.
Publicado: (2022)

Case Report: Biological treatment of epidermolysis bullosa acquisita: report on four cases and literature review
por: Szymański, Konrad, et al.
Publicado: (2023)

Mycophenolate mofetil (MMF) in the treatment of epidermolysis bullosa acquisita (EBA) long-term follow-up
por: Sami, Naveed
Publicado: (2015)

The association between clinical and laboratory findings of bullous pemphigoid and dipeptidyl peptidase-4 inhibitors in the elderly: a retrospective study
por: Bukvić Mokos, Zrinka, et al.
Publicado: (2020)

Porphyria Cutanea Tarda Masquerading as Epidermolysis Bullosa Acquisita: A Report of Two Cases
por: Deen, Kristyn, et al.
Publicado: (2015)

Pathological Relevance of Anti-Hsp70 IgG Autoantibodies in Epidermolysis Bullosa Acquisita
por: Tukaj, Stefan, et al.
Publicado: (2022)

Epidermolysis bullosa acquisita as an adverse effect from rituximab therapy: A case report
por: Wu, Xueqiong, et al.
Publicado: (2020)

Refractory Epidermolysis Bullosa Acquisita with Chronic Graft-versus-Host Disease Successfully Treated with Rituximab
por: Han, Ju Hee, et al.
Publicado: (2023)

The Syk Tyrosine Kinase Is Required for Skin Inflammation in an In Vivo Mouse Model of Epidermolysis Bullosa Acquisita
por: Németh, Tamás, et al.
Publicado: (2017)

Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita
por: Kovacs, Balint, et al.
Publicado: (2020)

Current Therapeutic Approach to Hypertrophic Scars
por: Mokos, Zrinka Bukvić, et al.
Publicado: (2017)

Treatment with anti‐neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice
por: Kasprick, Anika, et al.
Publicado: (2020)

C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita
por: Guerrero-Juarez, Christian F., et al.
Publicado: (2023)

Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita
por: Koga, Hiroshi, et al.
Publicado: (2018)

Accessible Diagnostic Methods to Differentiate between Epidermolysis Bullosa Acquisita and Other Subepidermal Autoimmune Bullous Diseases
por: Kridin, Khalaf
Publicado: (2018)

Epidermolysis Bullosa Acquisita: A Case Report of a Rare Clinical Phenotype and a Review of Literature
por: Beiu, Cristina, et al.
Publicado: (2019)

Preventive but Not Therapeutic Topical Application of Local Anesthetics Can Inhibit Experimental Epidermolysis Bullosa Acquisita in Mice
por: Wen, Lifang, et al.
Publicado: (2021)

Vesiculobullous Erythema Elevatum Diutinum: a Rare Variant With Epidermolysis Bullosa Acquisita-like Immunofluorescence Findings
por: Yalici-Armagan, Basak, et al.
Publicado: (2022)

Risk factors and sequelae of epidermolysis bullosa acquisita: A propensity-matched global study in 1,344 patients
por: Kridin, Khalaf, et al.
Publicado: (2023)

Diagnosis of Epidermolysis Bullosa Acquisita: Multicentre Comparison of Different Assays for Serum Anti-type VII Collagen Reactivity
por: HOLTSCHE, Maike Marleen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hii331ni64ss17iiiaruntkh5q